Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC (HKMPF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HKMPF · as of Jun 9, 2026
Key Statistics
Explore Hikma Pharmaceuticals PLC Data
hkmpf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 50.0%
Competitors & Peers
hkmpf competitorsHKMPF
DNPUF
FLMNF
GZPHF
HLBBF
HLUBFStock Performance
Full HistoryAbout Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC is a global pharmaceutical firm engaged in the development, manufacturing, commercialization, and distribution of a wide array of medications, including its own branded produ…
what is hikma pharmaceuticals plc · hkmpf stock overview · hikma pharmaceuticals plc company profile · who is hikma pharmaceuticals plc ceo · hkmpf OTC · hikma pharmaceuticals plc headquarters · hikma pharmaceuticals plc business segments
About Stock Overview & Key Data
Hikma Pharmaceuticals PLC (HKMPF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Aug 22, 2012. As of the latest trading session, HKMPF stock price is $19.07, with a market capitalization of $4.1B. The stock has returned -31.23% over the past 12 months and -8.93% year-to-date.
According to 2 Wall Street analysts, the consensus rating for Hikma Pharmaceuticals PLC stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Hikma Pharmaceuticals PLC reported revenue of $3.4B and net income of $410.9M. For detailed data — including Hikma Pharmaceuticals PLC revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Hikma Pharmaceuticals PLC (HKMPF) stock price is $19.07. The stock is traded on OTC under the ticker symbol HKMPF. The 52-week range is $16.34 – $27.96.